Validation of Bronchiectasis Health Questionnaire (BHQ) in Chinese Patients With Noncystic Fibrosis Bronchiectasis
Canadian Respiratory Journal · 2026-01 · 2026 (1)
DOI: 10.1155/carj/5551480 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Canadian Respiratory Journal, online erschienen am 22.07.2026. Verfasst von Wang Chun Kwok und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, The University of Hong Kong, 102 Pokfulam Road, Pokfulam, Hong Kong Special Administrative Region, China, hku.hk. Hauptthemen laut MEDLINE: Bronchiectasis, Quality of Life. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hong Kong Lung Foundation Research.
Abstract (Originalsprache)
Background
The Bronchiectasis Health Questionnaire (BHQ) was developed to assess the health‐related quality of life (HRQOL) in patients with noncystic fibrosis (CF) bronchiectasis. This study aimed to translate, culturally adapt, and validate the BHQ for use among Chinese patients.
Methods
The traditional Chinese version of the BHQ (TC‐BHQ) was created through a process of translation, cognitive debriefing interviews, and expert panel reviews. The psychometric evaluation of the TC‐BHQ encompassed assessments of factor structure, convergent validity, known‐group comparison, internal consistency, and test–retest reliability.
Results
We recruited 150 non‐CF bronchiectasis patients. Confirmatory factor analysis (CFA) supported the one‐factor structure of the BHQ. In terms of concurrent validity, the TC‐BHQ total score showed a significant correlation with the St. George’s Respiratory Questionnaire (SGRQ) total score ( r = −0.77, p < 0.01). In addition, the TC‐BHQ total score significantly correlated with all SGRQ subscale scores, including the symptom score ( r = −0.62, p < 0.01), activity score ( r = −0.60, p < 0.01), and impact score ( r = −0.75, p < 0.01). There was a statistically significant change in the total score between baseline and follow‐up ( p = 0.007). Both internal consistency and test–retest reliability of the TC‐BHQ were acceptable.
Conclusion
TC‐BHQ is a promising tool for assessing HRQOL in patients with non‐CF bronchiectasis. It has the potential to be a useful instrument in both clinical and research settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, The University of Hong Kong, 102 Pokfulam Road, Pokfulam, Hong Kong Special Administrative Region, China, hku.hk.
- School of Nursing, The University of Hong Kong, 5/F, Academic Building 3 Sassoon Road, Pokfulam, Hong Kong Special Administrative Region, China, hku.hk.
ORCID-Profile: Wang Chun Kwok, James Chung Man Ho, Edmond Pui Hang Choi
Förderung
- Hong Kong Lung Foundation Research
Zitieren
APA
Kwok, W. C., Tam, T. C. C., Chan, S. S. K., Ho, J. C. M., & Choi, E. P. H. (2026). Validation of Bronchiectasis Health Questionnaire (BHQ) in Chinese Patients With Noncystic Fibrosis Bronchiectasis. Canadian Respiratory Journal, 2026(1). https://doi.org/10.1155/carj/5551480
Vancouver
Kwok WC, Tam TCC, Chan SSK, Ho JCM, Choi EPH. Validation of Bronchiectasis Health Questionnaire (BHQ) in Chinese Patients With Noncystic Fibrosis Bronchiectasis. Canadian Respiratory Journal. 2026;2026(1). doi:10.1155/carj/5551480
BibTeX
@article{Kwok2026,
author = {Kwok, Wang Chun and Tam, Terence Chi Chun and Chan, Samuel Shung Kay and Ho, James Chung Man and Choi, Edmond Pui Hang},
title = {Validation of Bronchiectasis Health Questionnaire (BHQ) in Chinese Patients With Noncystic Fibrosis Bronchiectasis},
journal = {Canadian Respiratory Journal},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/carj/5551480}
}
EUVIMED